These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 9663496)
1. Use of various methods for anticardiolipin detection in the updated American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: comment on the letter by Hochberg. Tsutsumi A; Ichikawa K; Atsumi T; Matsuura E; Koike T; Krilis SA Arthritis Rheum; 1998 Jul; 41(7):1326-7. PubMed ID: 9663496 [No Abstract] [Full Text] [Related]
2. The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed? Feletar M; IbaƱez D; Urowitz MB; Gladman DD Arthritis Rheum; 2003 Jul; 48(7):2067-9. PubMed ID: 12847702 [No Abstract] [Full Text] [Related]
3. Validation of the Sapporo criteria for antiphospholipid syndrome. Lockshin MD; Sammaritano LR; Schwartzman S Arthritis Rheum; 2000 Feb; 43(2):440-3. PubMed ID: 10693886 [TBL] [Abstract][Full Text] [Related]
4. Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus. Costenbader KH; Karlson EW; Mandl LA J Rheumatol; 2002 Dec; 29(12):2545-50. PubMed ID: 12465149 [TBL] [Abstract][Full Text] [Related]
5. Review of classification criteria for systemic lupus erythematosus. Petri M Rheum Dis Clin North Am; 2005 May; 31(2):245-54, vi. PubMed ID: 15922144 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection. Kalt M; Gertner E J Rheumatol; 2001 Oct; 28(10):2335-6. PubMed ID: 11669178 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus. Sahin M; Duzgun N; Tunc SE; Tutkak H Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958 [TBL] [Abstract][Full Text] [Related]
8. Anticardiolipin antibodies and beta 2-glycoprotein I. Koike T; Matsuura E Lupus; 1996 Apr; 5(2):156-7. PubMed ID: 8743131 [No Abstract] [Full Text] [Related]
9. Revision of the Sapporo criteria for the antiphospholipid syndrome-- coming to grips with evidence and Thomas Bayes? Lackner KJ; Peetz D; von Landenberg P Thromb Haemost; 2006 Jun; 95(6):917-9. PubMed ID: 16732366 [No Abstract] [Full Text] [Related]
10. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot]. Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158 [TBL] [Abstract][Full Text] [Related]
11. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267 [TBL] [Abstract][Full Text] [Related]
12. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus]. Borodin AG; Baranov NG; Nasonov EL Klin Med (Mosk); 2001; 79(2):49-51. PubMed ID: 11419087 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to beta2-glycoprotein I in anticardiolipin negative patients. Picillo U; Marcialis MR; Italiano G J Rheumatol; 1998 Jul; 25(7):1440-2. PubMed ID: 9676785 [No Abstract] [Full Text] [Related]
14. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672 [TBL] [Abstract][Full Text] [Related]
15. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity]. Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587 [TBL] [Abstract][Full Text] [Related]
16. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C Lupus; 2007; 16(10):810-6. PubMed ID: 17895304 [TBL] [Abstract][Full Text] [Related]
17. Updating the American College of Rheumatology criteria for systemic lupus erythematosus: comment on the letter by Hochberg. Piette JC Arthritis Rheum; 1998 Apr; 41(4):751. PubMed ID: 9550492 [No Abstract] [Full Text] [Related]
19. Reticulate and stellate acral pigmentation associated with systemic lupus erythematosus and high titers of circulating anticardiolipin antibodies: a possible association with acral microlivedo. Scheinfeld NS; DiCostanzo DD; Cohen SR J Drugs Dermatol; 2003 Dec; 2(6):674-6. PubMed ID: 14711150 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]